Therapeutic cancer vaccines often fail to generate strong enough immune responses, in part because traditional “blender-style” formulations ignore how the structural arrangement of components ...
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results